EQS-Media / 10.02.2025 / 11:17 CET/CEST Frankfurt am Main, February 25, 2025 - PARMANTIER & CIE. has updated its coverage of CLINUVEL Pharmaceuticals Ltd.
Clinuvel is an Australia-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of genetic and metabolic disorders.